More Effectively Using Registries to suppOrt PAtient-centered Regulatory and HTA decision-making

Rezultaty

Report on evidence needs defined by stakeholders across the lifecycle of medicinal products. Report contains summary of evidence needs formulated such that they can be translated to quantifiable concepts for use in desig and analyses of trials and RWD from registries.

Registries identification machine learning tool

Natural language processing-powered tool for identifications of the registries and key opinion leaders based on automated systematic literature review (including, code, documentation, and methodology description)

Data collection (feasibility)

report on the description of data from multiple sclerosis patients treated with rituximab and dimethyl fumarate from all contributing registries. This will, in addition to treatment information, include personal, clinical and other treatment data and be specified per country.

Dissemination and exploitation plan

A report of the communication and dissemination plan will be written on the dissemination strategy towards key stakeholders to ensure an uptake of the project outcomes. The plan will include the set-up of More-EUROPA's website with content relevant for both the project members and the wider, lay-men’s audience, and will cover social media activities presentation templates and networking activities.

Registries identification guidelines

Recommendations for registries identification; modelling plan for the tool development

Stakeholder kick-off

A report will be written on the kick-off stakeholder conference with a project overview and appraisal of key stakeholders’ perspectives on implementing registry-based RWD/RWE in regulatory and HTA decision making.

Report on the state of the art and unmet needs

Detailed document discussing the current practices of registry identification and assessment in Europe and worldwide.

Publikacje

Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure

Autorzy: Alessandro Villaschi, Christian Basile, Lina Benson, Paolo Gatti, William T. Abraham, Michael Böhm, Biykem Bozkurt, Javed Butler, Gianluigi Condorelli, Cecilia Linde, Marco Metra, Wilfried Mullens, Peter Mol, Shelley Zieroth, Raffaele Scorza, Lars H. Lund, Fredrik Gadler, Gianluigi Savarese
Opublikowane w: JACC: Heart Failure, Numer 13, 2025, ISSN 2213-1779
Wydawca: Elsevier BV
DOI: 10.1016/J.JCHF.2025.102515

Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries

Autorzy: Markus Wallner, Mattia Emanuele Biber, Davide Stolfo, Gianfranco Sinagra, Lina Benson, Ulf Dahlström, Soffia Gudbjörnsdottir, Francesco Cosentino, Peter G M Mol, Giuseppe M C Rosano, aved Butler, Marco Metra, MD, Lars H Lund, Giulia Ferrannini, Gianluigi
Opublikowane w: European Heart Journal - Cardiovascular Pharmacotherapy, ISSN 2055-6845
Wydawca: Oxford
DOI: 10.1093/EHJCVP/PVAE026

Associations between cardiac resynchronization therapy and clinical outcomes according to the atrial fibrillation status in patients with heart failure with reduced ejection fraction

Autorzy: Renzo Laborante, Valeria Valente, Lina Benson, Paolo Gatti, Christian Basile, Alessandro Villaschi, Peter Moritz Becher, Domenico D’Amario, Carin Corovic-Cabrera, Fredrik Gadler, Gianluigi Savarese, Raffaele Scorza
Opublikowane w: Europace, Numer 27, 2025, ISSN 1099-5129
Wydawca: Oxford University Press (OUP)
DOI: 10.1093/EUROPACE/EUAF296

Safety of continuing mineralocorticoid receptor antagonist treatment in patients with heart failure with reduced ejection fraction and severe kidney disease: Data from Swedish Heart Failure Registry

Autorzy: Federica Guidetti, Lars H. Lund, Lina Benson, Camilla Hage, Francesca Musella, Davide Stolfo, Peter G.M. Mol, Andreas J. Flammer, Frank Ruschitzka, Ulf Dahlstrom, Giuseppe M.C. Rosano, Oscar Ö. Braun, Gianluigi Savarese
Opublikowane w: European Journal of Heart Failure, 2023, ISSN 1879-0844
Wydawca: Wiley
DOI: 10.1002/ejhf.3049

Eligibility for vericiguat in a real-world heart failure population according to trial, guideline and label criteria: Data from the Swedish Heart Failure Registry

Autorzy: Nguyen NV, Lindberg F, Benson L, Ferrannini G, Imbalzano E, Mol PGM, Dahlström U, Rosano GMC, Ezekowitz J, Butler J, Lund LH, Savarese G.
Opublikowane w: European Journal of Heart Failure, ISSN 1879-0844
Wydawca: Wiley
DOI: 10.1002/EJHF.2939

RWD16 An AI-Powered Tool to Identify and Assess Fit-for-Use Registries for Drug Development and Evaluation

Autorzy: Ghinwa Y. Hayek, Boris Kopin, Sonia Zebachi, Gaëtan Pinon, Basile Ferry, Elisabeth Bakker, Alexandre Macquin, Sieta de Vries, Peter GM. Mol, Billy Amzal
Opublikowane w: Value in Health, Numer 28, 2025, ISSN 1098-3015
Wydawca: Elsevier BV
DOI: 10.1016/J.JVAL.2025.09.2766

Characteristics, use of guideline–recommended medical therapies and clinical outcomes of patients with heart failure not enrolled in a quality registry: a comparison with the Swedish Heart Failure Registry

Autorzy: Ailema González-Ortiz, Paul Hjemdahl, Faizan Mazhar, Alessandro Bosi, Anne-Laure Faucon, Gianluigi Savarese, Lars H Lund, Juan Jesus Carrero
Opublikowane w: European Heart Journal - Quality of Care and Clinical Outcomes, Numer 11, 2025, ISSN 2058-5225
Wydawca: Oxford University Press (OUP)
DOI: 10.1093/EHJQCCO/QCAF019

Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry

Autorzy: Lindberg F, Øigaard N, Metra M, Rosano GMC, Dahlström U, Mol P, Hage C, Lund LH, Savarese G.
Opublikowane w: PLoS ONE, ISSN 1932-6203
Wydawca: PLOS
DOI: 10.1371/JOURNAL.PONE.0303348

European Journal of Heart Failure

Autorzy: Benedikt N. Beer; Lina Benson; Christian Basile; Benedikt Schrage; Peter Moritz Becher; Stefan Blankenberg; Paulus Kirchhof; Barna Szabó‐Söderberg; Marco Metra; Anne Lindberg; Egidio Imbalzano; Giuseppe M. C. Rosano; Patric Karlström; Peter G.M. Mol; Raffaele Scorza; Lars H. Lund; Felix Lindberg; Gianluigi Savarese
Opublikowane w: European Journal of Heart Failure, 2025, ISSN 1388-9842
Wydawca: Elsevier BV
DOI: 10.1002/EJHF.70046

Leveraging patient experience data to guide medicines development, regulation, access decisions and clinical care in the EU

Autorzy: Almeida D, Umuhire D, Gonzalez-Quevedo R, António A, Burgos JG, Verpillat P, Bere N, Sepodes B, Torre C.
Opublikowane w: Frontiers in Medicine, ISSN 2296-858X
Wydawca: Frontiers
DOI: 10.3389/FMED.2024.1408636

Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry

Autorzy: Amerigo Ferrari, Davide Stolfo, Alicia Uijl, Nicola Orsini, Lina Benson, Gianfranco Sinagra, Peter Mol, Sieta T. de Vries, Ulf Dahlström, Giuseppe Rosano, Lars H. Lund, Gianluigi Savarese
Opublikowane w: European Journal of Heart Failure, ISSN 1879-0844
Wydawca: Wiley
DOI: 10.1002/EJHF.3272

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real‐World Data Sources for Fit‐for‐Purpose Studies

Autorzy: Sonia Zebachi, Julien Tanniou, Elisabeth Bakker, Sieta T. de Vries, Rossella Di Bidino, Entela Xoxi, Anna Glaser, Gianluigi Savarese, Jan Hillert, Peter G. M. Mol, Kelly Plueschke, Billy Amzal, Ghinwa Y. Hayek, Jeverson Moreira
Opublikowane w: Clinical Pharmacology & Therapeutics, Numer 118, 2025, ISSN 0009-9236
Wydawca: Wiley
DOI: 10.1002/CPT.3746

Withdrawal of Guideline-Directed Medical Therapy in Patients With Heart Failure and Improved Ejection Fraction

Autorzy: Christian Basile, Felix Lindberg, Lina Benson, Federica Guidetti, Ulf Dahlström, Massimo Francesco Piepoli, Peter Mol, Raffaele Scorza, Aldo Pietro Maggioni, Lars H. Lund, Gianluigi Savarese
Opublikowane w: Circulation, Numer 151, 2025, ISSN 0009-7322
Wydawca: Ovid Technologies (Wolters Kluwer Health)
DOI: 10.1161/CIRCULATIONAHA.124.072855

Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry

Autorzy: Becher PM, Savarese G, Benson L, Dahlström U, Karlström P, Mol PGM, Metra M, Bhatt DL, Pitt B, Lund LH.
Opublikowane w: European Heart Journal - Cardiovascular Pharmacotherapy, ISSN 2055-6845
Wydawca: Oxford
DOI: 10.1093/EHJCVP/PVAD012

Decision‐Making Criteria and Methods for Initiating Late‐Stage Clinical Trials in Drug Development From a Multi‐Stakeholder Perspective: A Scoping Review

Autorzy: Ce Jiang, Céline Beji, Sonia Zebachi, Ghinwa Y. Hayek, Aysun Cetinyurek‐Yavuz, Muhammad Bergas N. Fayyad, Laura Rodwell, Kit C. B. Roes, Billy Amzal, Christoph Gerlinger, Raphaël Porcher, Julien Tanniou
Opublikowane w: Clinical Pharmacology & Therapeutics, Numer 117, 2025, ISSN 0009-9236
Wydawca: Wiley
DOI: 10.1002/CPT.3566

Ethics practices associated with reusing health data: An assessment of patient registries

Autorzy: Olmo van den Akker, Susanne Stark, Daniel Strech
Opublikowane w: medRxiv, ISSN 0000-0000
Wydawca: x
DOI: 10.1101/2024.04.26.24306459

What Are Unmet Needs for the Use of Registries in Regulatory/HTA Decision-Making in Europe? A Survey-Based Approach From the More-EUROPA Project

Autorzy: J. Moreira, J. Tanniou, P. Tang, P. Godbillot, F.Ahrens, B. Amzal
Opublikowane w: Value in Health, ISSN 1098-3015
Wydawca: Blackwell Publishing Inc.
DOI: 10.1016/J.JVAL.2023.09.2150

Criteria and Methods Applied to Decision-Making to Embark on Late-Stage Clinical Trials With a Multi-Stakeholder Perspective

Autorzy: C. Jiang, J.Tanniou, B. Amzal
Opublikowane w: Value in Health, ISSN 1098-3015
Wydawca: Blackwell Publishing Inc.
DOI: 10.1016/J.JVAL.2023.09.2148

Decision-Making Criteria and Methods for Initiating Late-Stage Clinical Trials from a Multi-Stakeholder Perspective: A Scoping Review

Autorzy: Ce Jiang, Céline Beji, Sonia Zebachi, Ghinwa Hayek, Aysun CetinyurekYavuz, Bergas Fayyad, Laura Rodwell, Kit C.B. Roes, Billy Amzal, Christoph Gerlinger, Raphaël Porcher, Julien Tanniou
Opublikowane w: 2025
Wydawca: PSI 2025 Conference

Decision-Making Criteria and Methods for Initiating Late-Stage Clinical Trials in Drug Development From a Multi-Stakeholder Perspective: A Scoping Review

Autorzy: Ce Jiang, Céline Beji, Sonia Zebachi, Ghinwa Hayek, Aysun CetinyurekYavuz, Bergas Fayyad, Laura Rodwell, Kit C.B. Roes, Billy Amzal, Christoph Gerlinger, Raphaël Porcher, Julien Tanniou
Opublikowane w: 2025
Wydawca: SnB Conference

An AI powered tool to identify and assess fit-for-use registries for real-world evidence

Autorzy: Ghinwa Y. Hayek, Pascal Godbillot, Coriande Clemente, Sonia Zebachi, Gaëtan Pinon, Boris Kopin, Elisabeth Bakker, Sieta T. de Vries, Peter G.M. Mol, Billy Amzal
Opublikowane w: European Drug Utilization Conference 2025, 2025
Wydawca: European Drug Utilization Conference

Existing Automated Tools to Assist Evidence Generation and Better Qualification of Registries and Real-World Data: A Systematic Review From the More-EUROPA Project

Autorzy: P. Godbillot, P. Tang, J. Moreira, J. Tanniou, S. Zebachi, B. Amzal
Opublikowane w: Value in Health, ISSN 1098-3015
Wydawca: Elsevier
DOI: 10.1016/J.JVAL.2023.09.2120

Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real-World Data Sources for Fit-for-Purpose Studies

Autorzy: Sonia Zebachi, Julien Tanniou, Elisabeth Bakker, Sieta T. de Vries, Rossella di Bidino, Entela Xoxi, Anna Glaser, Gianluigi Savarese, Jan Hillert, Peter G.M. Mol, Kelly Plueschke, Ghinwa Hayek, Billy Amzal, Jeverson Moreira
Opublikowane w: European Drug Utilization Conference 2025, 2025
Wydawca: European Drug Utilization Conference 2025

Existing Automated Tools to Assist Evidence Generation and Better Qualification of Registries and Real-World Data: A Systematic Review From the More-EUROPA Project

Autorzy: S. Zebachi, J. Moreira, J. Tanniou, P. Godbillot, P. Tang, B. Amzal
Opublikowane w: Value in Health, ISSN 1098-3015
Wydawca: Blackwell Publishing Inc.
DOI: 10.1016/J.JVAL.2023.09.2089

Rezultaty

Publikacje

Udostępnij tę stronę Udostępnij tę stronę w mediach społecznościowych

Pobierz Pobierz zawartość strony